+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 279 Pages
  • Global
From
Beta Interferon - Global Strategic Business Report - Product Thumbnail Image

Beta Interferon - Global Strategic Business Report

  • Report
  • August 2026
  • 138 Pages
  • Global
From
Skin Allergy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Skin Allergy Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 130 Pages
  • Global
From
Corticosteroids Therapy - Global Strategic Business Report - Product Thumbnail Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • August 2026
  • 282 Pages
  • Global
From
Eye Allergy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Eye Allergy Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 190 Pages
  • Global
From
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 263 Pages
  • Global
From
Endometriosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 191 Pages
  • Global
From
Glucosamine - Global Strategic Business Report - Product Thumbnail Image

Glucosamine - Global Strategic Business Report

  • Report
  • August 2026
  • 350 Pages
  • Global
From
From
Ocular Immunosuppressants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ocular Immunosuppressants Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2026-2032 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 188 Pages
  • Global
From
Allergy Clinical Trial Services Global Market Report 2026 - Product Thumbnail Image

Allergy Clinical Trial Services Global Market Report 2026

  • Report
  • May 2026
  • 250 Pages
  • Global
From
From
Gout Therapeutics Market Report 2026 - Product Thumbnail Image

Gout Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Crohn's Disease Treatment Market Report 2026 - Product Thumbnail Image

Crohn's Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Market Report 2026 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lupus Therapeutics Market Report 2026 - Product Thumbnail Image

Lupus Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more